> HDMA Testifies
      Supporting HR5839

> HDMA Applauds
      Introduction of
      HR 5839

> HDMA Applauds
      NCPA, FBI LEEDA and
      Purdue Pharma

> HDMA Commends
      California Board of
      Pharmacy Decision

> New Data Management
      & Sharing Research
      Now Available!


print page

 

 

 

Contact:
Amanda Forster, HDMA, 703-885-0225
aforster@hdmanet.org

HDMA JOINS THE FDA COUNTERFEIT ALERT NETWORK

ARLINGTON, VA — May 12, 2006 — As part of ongoing efforts to fight the threat of counterfeit drugs to the U.S. medicine supply, the Healthcare Distribution Management Association (HDMA) joined the Food and Drug Administration’s (FDA) Counterfeit Alert Network.

The Counterfeit Alert Network is designed to inform consumers, pharmacists, healthcare professionals, distributors and other healthcare organizations of counterfeit drug incidents, and provides education on ways to identify and prevent counterfeits from entering the U.S. medicine supply. 

“HDMA members serve as the central link in a sophisticated supply chain. As such, we have a responsibility to work closely with government, manufacturers, providers and law enforcement to safeguard patient health,” said HDMA President and CEO John M. Gray. “Patient safety and supply chain security is our members’ greatest concern, and we strongly support efforts to further secure the U.S. healthcare system.”

As a partner in the Counterfeit Alert Network, HDMA will distribute time-sensitive FDA messages and information on specific counterfeit incidents to member distribution companies.  HDMA also will provide educational messages about counterfeit drugs, as well as information needed to recognize and report suspect or counterfeit drug products to FDA. 

Joining the Counterfeit Alert Network is the latest in a series of measures led by HDMA to fight the threat of counterfeit drugs.  HDMA has and will continue to petition states across the United States to crack down on criminals who seek to obtain drug distribution licenses, and has been leading the call for stricter licensing standards, stronger regulations, greater enforcement, tougher criminal penalties and best business practices to help secure the nation’s medicine supply. HDMA is also a strong advocate for current and emerging anti-counterfeiting technologies, such as EPC/RFID.


About HDMA

The Healthcare Distribution Management Association (HDMA) and its members are committed to patient safety by delivering life-saving health products and services through a secure and efficient healthcare distribution system.  These primary healthcare distributors, representing more than 90 percent of the distribution system, are responsible for ensuring that billions of units of medication are safely delivered -- to tens of thousands of retail pharmacies, nursing homes, clinics and providers -- in all 50 states. For more than 125 years, HDMA and its members have been the vital link in the healthcare system that is responsible for medicine safety, quality, integrity and availability in the marketplace.  Through leadership on public policy and industry best practices, HDMA and its members focus on providing value, removing costs and developing innovative solutions to deliver care safely and effectively.
 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D